accountTiGenix NV of Belgium and Cellerix SA of Spain have agreed to merge creating what is expected to be the largest cell therapy and regenerative medicine company in Europe. It is the most significant corporate transaction in the field of regenerative medicine since the December 2010 alliance between Cephalon Inc and Mesoblast Ltd of Australia.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to TiGenix to merge with Spanish stem-cell company
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account